BRPI0900057B8 - processo para a obtenção de um concentrado de fator de von willebrand ou de um complexo de fator viii/fator de von willebrand e uso dos mesmos - Google Patents

processo para a obtenção de um concentrado de fator de von willebrand ou de um complexo de fator viii/fator de von willebrand e uso dos mesmos

Info

Publication number
BRPI0900057B8
BRPI0900057B8 BRPI0900057A BRPI0900057A BRPI0900057B8 BR PI0900057 B8 BRPI0900057 B8 BR PI0900057B8 BR PI0900057 A BRPI0900057 A BR PI0900057A BR PI0900057 A BRPI0900057 A BR PI0900057A BR PI0900057 B8 BRPI0900057 B8 BR PI0900057B8
Authority
BR
Brazil
Prior art keywords
von willebrand
willebrand factor
factor
complex
concentrate
Prior art date
Application number
BRPI0900057A
Other languages
English (en)
Inventor
Ignacio Jorquera Nieto Juan
Mercedes Faro Tomas Maria
Ristol Debart Pere
Original Assignee
Grifols Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39316136&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0900057(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grifols Sa filed Critical Grifols Sa
Publication of BRPI0900057A2 publication Critical patent/BRPI0900057A2/pt
Publication of BRPI0900057B1 publication Critical patent/BRPI0900057B1/pt
Publication of BRPI0900057B8 publication Critical patent/BRPI0900057B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)

Abstract

processo para a obtenção de um concentrado de fator de von willebrand ou de um complexo de fator viii/fator de von willebrand e uso dos mesmos. a presente invenção refere-se a um processo para a preparação de um concentrado de fator de von willebrand ou de um complexo de fator viii/fator de von willebrand e uso dos mesmos. o processo é caracterizado pela preparação de uma solução de fator de von willebrand ou de um complexo de fator viii/fator de von willebrand que contém vwf e uma concentração de até 12 iu de vwf:rco/ml e uma razão de fator de von willebrand /fator viii de 0,4 ou mais e então prosseguindo-se com a nanofiltração da solução preparada em a) através de um filtro que tem um tamanho de poro menor do que 35 nanometros.
BRPI0900057A 2008-01-08 2009-01-06 processo para a obtenção de um concentrado de fator de von willebrand ou de um complexo de fator viii/fator de von willebrand e uso dos mesmos BRPI0900057B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200800021 2008-01-08
ES200800021A ES2298096B1 (es) 2008-01-08 2008-01-08 Procedimiento para la obtencion de un concentrado de factor von willebrand o del complejo de factor viii/factor von willebrand y utilizacionde los mismos.

Publications (3)

Publication Number Publication Date
BRPI0900057A2 BRPI0900057A2 (pt) 2009-09-22
BRPI0900057B1 BRPI0900057B1 (pt) 2021-03-23
BRPI0900057B8 true BRPI0900057B8 (pt) 2021-06-29

Family

ID=39316136

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0900057A BRPI0900057B8 (pt) 2008-01-08 2009-01-06 processo para a obtenção de um concentrado de fator de von willebrand ou de um complexo de fator viii/fator de von willebrand e uso dos mesmos

Country Status (17)

Country Link
US (2) US8354505B2 (pt)
EP (1) EP2078730B9 (pt)
JP (1) JP4976366B2 (pt)
CN (1) CN101480490B (pt)
AR (1) AR072441A1 (pt)
AT (1) ATE509031T1 (pt)
AU (1) AU2008255137C1 (pt)
BR (1) BRPI0900057B8 (pt)
CA (1) CA2645701C (pt)
CL (1) CL2009000022A1 (pt)
ES (2) ES2298096B1 (pt)
HK (1) HK1129075A1 (pt)
MX (1) MX2008015892A (pt)
NZ (1) NZ573400A (pt)
PL (1) PL2078730T3 (pt)
PT (1) PT2078730E (pt)
RU (1) RU2417096C2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861395B1 (fr) * 2003-10-23 2006-02-17 Lab Francais Du Fractionnement Facteur viii viralement securise a faible teneur en multimeres superieurs
US11197916B2 (en) 2007-12-28 2021-12-14 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
CN105816858A (zh) 2007-12-28 2016-08-03 巴克斯特国际公司 重组vwf配方
AU2009307648C1 (en) 2008-10-21 2016-12-08 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
KR20190041032A (ko) * 2011-06-10 2019-04-19 박스알타 인코퍼레이티드 재조합 vwf의 투여에 의한 응고 질환의 치료
JP5711369B2 (ja) 2011-06-24 2015-04-30 旭化成メディカル株式会社 蛋白製剤の製造方法
BR112014017165B1 (pt) * 2012-01-12 2023-05-02 Bioverativ Therapeutics Inc Proteína quimérica compreendendo uma proteína de fator viii, composição farmacêutica, e seus usos
EP2841451A1 (en) 2012-04-24 2015-03-04 Novo Nordisk A/S Compounds suitable for treatment of haemophilia
AU2014346343B2 (en) * 2013-11-08 2018-05-10 Csl Ltd. New method to concentrate von Willebrand factor or complexes thereof
RU2714154C2 (ru) * 2014-06-06 2020-02-12 Октафарма Аг Препарат, содержащий фактор viii и пептиды фактора фон виллебранда
CN104804078B (zh) * 2015-05-05 2019-01-04 广东卫伦生物制药有限公司 人体血清凝血因子ⅷ中的病毒过滤方法
KR20200038309A (ko) 2017-08-23 2020-04-10 체에스엘 베링 게엠베하 폰 빌레브란트 인자의 바이러스 여과 방법
CA3228445A1 (en) 2021-08-11 2023-02-16 Salvador Grancha Gamon Method for producing human plasma-derived factor viii / von willebrand factor and composition obtained

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110907A (en) * 1989-08-01 1992-05-05 Alpha Therapeutic Corporation Factor viii complex purification using heparin affinity chromatography
US5288853A (en) 1992-04-30 1994-02-22 Alpha Therapeutic Corporation Factor viii purification process
EP0860444A1 (en) * 1997-02-24 1998-08-26 Stichting Centraal Laboratorium van de Bloedtransfusiedienst van het Nederlandse Rode Kruis (CLB) Method for removing viruses from a protein solution
AT406373B (de) 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
AT405485B (de) * 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
FR2772381B1 (fr) * 1997-12-15 2001-06-08 Lab Francais Du Fractionnement Procede de preparation par filtration d'une solution de facteur viii securisee viralement
FR2861395B1 (fr) * 2003-10-23 2006-02-17 Lab Francais Du Fractionnement Facteur viii viralement securise a faible teneur en multimeres superieurs
FR2874216B1 (fr) * 2004-08-16 2006-11-03 Lab Francais Du Fractionnement Procede de preparation d'un concentre de facteur von willebrand (fvw) par voie chromatographique et concentre de fvw susceptible d'etre ainsi obtenu

Also Published As

Publication number Publication date
ES2298096A1 (es) 2008-05-01
CN101480490A (zh) 2009-07-15
ES2298096B1 (es) 2009-01-01
RU2417096C2 (ru) 2011-04-27
MX2008015892A (es) 2009-07-07
BRPI0900057B1 (pt) 2021-03-23
EP2078730B9 (en) 2011-12-21
ATE509031T1 (de) 2011-05-15
PL2078730T3 (pl) 2011-10-31
JP4976366B2 (ja) 2012-07-18
EP2078730B1 (en) 2011-05-11
US20110275570A1 (en) 2011-11-10
CA2645701C (en) 2013-09-17
US8354505B2 (en) 2013-01-15
CN101480490B (zh) 2013-05-29
AU2008255137B2 (en) 2011-04-07
CA2645701A1 (en) 2009-07-08
EP2078730A1 (en) 2009-07-15
US20090176709A1 (en) 2009-07-09
JP2009161528A (ja) 2009-07-23
AR072441A1 (es) 2010-09-01
BRPI0900057A2 (pt) 2009-09-22
CL2009000022A1 (es) 2009-11-20
HK1129075A1 (en) 2009-11-20
PT2078730E (pt) 2011-07-14
AU2008255137C1 (en) 2015-08-27
NZ573400A (en) 2010-02-26
AU2008255137A1 (en) 2009-07-23
ES2363827T3 (es) 2011-08-17
RU2008151957A (ru) 2010-07-10

Similar Documents

Publication Publication Date Title
BRPI0900057B8 (pt) processo para a obtenção de um concentrado de fator de von willebrand ou de um complexo de fator viii/fator de von willebrand e uso dos mesmos
BR112017009252A2 (pt) solução de nicotina, sistema eletrônico de fornecimento de vapor, processo para melhorar as propriedades sensoriais de uma solução de nicotina vaporizada e uso de um ou mais ácidos
BRPI0710485B1 (pt) composições líquidas úteis no tratamento de doenças respiratórias
BR112015008186A2 (pt) formulação de um anticorpo estável e de baixa viscosidade
BR112014029754B1 (pt) soluções de tensoativos que contêm n-metil-noleilglucaminas e n-metil-n-c12-c14 acilglucaminas e seu uso, processo para produzir composições cosméticas e composição
BR112015008487A2 (pt) compostos de benzeno substituído
BR112013020513A2 (pt) adoçante stevia altamente solúvel
BR112015010915A2 (pt) conversor catalítico de três vias usando nano-partículas
EA201791850A1 (ru) Борсодержащие малые молекулы
BR112014029716A2 (pt) remoção de fenol em processo de recuperação de paraxileno
GT201300121A (es) Derivados de 2,3-dihidroimidazo(1,2-c)quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogénesis
BR112015012316A2 (pt) composições coletoras mistas
BR112015002372A2 (pt) composições e métodos para a redução do teor de álcool no sangue
BR112015021994A2 (pt) composição do papel
AR065963A1 (es) Solucion acuosa de peroxido de hidrogeno, proceso para su preparacion y su uso
BR112014013923A2 (pt) método para produção de mulita percolada num corpo de material, mulita percolada, uso da mulita percolada e corpo de material
BR112015017843A2 (pt) composição de fertilizante e método para colocar em suspensão o fertilizante em uma solução aquosa
BR112018003086A2 (pt) processo para captura de dióxido de carbono e dessalinação
CO7101247A2 (es) Formulaciones de ácido poliinosínico-policitidílico (poli(i:c)) para el tratamiento de infecciones de las vías respiratorias altas
PE20130728A1 (es) Complejo obtenido a partir de mezclas de acido hialuronico o una sal del mismo y sulfato de condroitina
BR112012008666A2 (pt) processo para a preparação de um pó, formulação, e, uso do pó preparado por um processo
BR112017022971A2 (pt) aperfeiçoamentos em ou com relação a compostos orgânicos
BR102015012091A8 (pt) método para a preparação de uma solução de albumina humana, e, composição
EA201100730A1 (ru) Комплекс включения пиноцембрина с циклодекстрином, способ его получения и применения
BR112014016950A8 (pt) métodos de promoção da cicatrização de úlceras diabéticas utilizando beta-hidróxi-beta-metilbutirato com arginina e glutamina

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B03H Publication of an application: rectification [chapter 3.8 patent gazette]

Free format text: REFERENTE A RPI 2020 DE 22/09/2009, QUANTO AO ITEM (72)

B25G Requested change of headquarter approved

Owner name: GRIFOLS, S.A. (ES)

B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/03/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/01/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2620 DE 23/03/2021 QUANTO AO ENDERECO.